197 related articles for article (PubMed ID: 24698514)
1. Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.
Maluf DG; Dumur CI; Suh JL; Lee JK; Cathro EP; King AL; Gallon L; Brayman KL; Mas VR
Am J Transplant; 2014 May; 14(5):1152-1163. PubMed ID: 24698514
[TBL] [Abstract][Full Text] [Related]
2. An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
Rhone ET; Bardhi E; Bontha SV; Walker PD; Almenara JA; Dumur CI; Cathro H; Maluf D; Mas V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063776
[TBL] [Abstract][Full Text] [Related]
3. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
4. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.
Kurian SM; Williams AN; Gelbart T; Campbell D; Mondala TS; Head SR; Horvath S; Gaber L; Thompson R; Whisenant T; Lin W; Langfelder P; Robison EH; Schaffer RL; Fisher JS; Friedewald J; Flechner SM; Chan LK; Wiseman AC; Shidban H; Mendez R; Heilman R; Abecassis MM; Marsh CL; Salomon DR
Am J Transplant; 2014 May; 14(5):1164-72. PubMed ID: 24725967
[TBL] [Abstract][Full Text] [Related]
5. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
Lefaucheur C; Gosset C; Rabant M; Viglietti D; Verine J; Aubert O; Louis K; Glotz D; Legendre C; Duong Van Huyen JP; Loupy A
Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients.
Kuypers DR; Naesens M; de Jonge H; Lerut E; Verbeke K; Vanrenterghem Y
Ther Drug Monit; 2010 Aug; 32(4):394-404. PubMed ID: 20526235
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling of belatacept and calcineurin inhibitor therapy in renal allograft recipients.
Vitalone MJ; Ganguly B; Hsieh S; Latek R; Kulbokas EJ; Townsend R; Sarwal MM
Am J Transplant; 2014 Aug; 14(8):1912-21. PubMed ID: 24954576
[TBL] [Abstract][Full Text] [Related]
8. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
9. Chronic allograft dysfunction: major contributing factors.
Ganji MR; Harririan A
Iran J Kidney Dis; 2012 Mar; 6(2):88-93. PubMed ID: 22388603
[TBL] [Abstract][Full Text] [Related]
10. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies.
Kambham N; Nagarajan S; Shah S; Li L; Salvatierra O; Sarwal MM
Clin J Am Soc Nephrol; 2007 Jan; 2(1):135-42. PubMed ID: 17699397
[TBL] [Abstract][Full Text] [Related]
11. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis.
Maluf DG; Mas VR; Archer KJ; Yanek K; Gibney EM; King AL; Cotterell A; Fisher RA; Posner MP
Mol Med; 2008; 14(5-6):276-85. PubMed ID: 18286166
[TBL] [Abstract][Full Text] [Related]
13. Effects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi-Omics Approach.
Bontha SV; Maluf DG; Archer KJ; Dumur CI; Dozmorov MG; King AL; Akalin E; Mueller TF; Gallon L; Mas VR
Am J Transplant; 2017 Dec; 17(12):3060-3075. PubMed ID: 28556588
[TBL] [Abstract][Full Text] [Related]
14. Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.
Oetjens M; Bush WS; Birdwell KA; Dilks HH; Bowton EA; Denny JC; Wilke RA; Roden DM; Crawford DC
Pac Symp Biocomput; 2014; ():253-64. PubMed ID: 24297552
[TBL] [Abstract][Full Text] [Related]
15. Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management.
Zotta F; Guzzo I; Morolli F; Diomedi-Camassei F; Dello Strologo L
Pediatr Nephrol; 2018 Nov; 33(11):2167-2175. PubMed ID: 29980849
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural alterations in endothelial mitochondria are associated with enhanced nitrotyrosine accumulation and progressive reduction of VEGF expression in sequential protocol renal allograft biopsies with calcineurin inhibitor toxicity.
Sharma A; Jain S; Gupta R; Banerjee KG; Guleria S; Agarwal SK; Dinda AK
Transpl Int; 2010 Apr; 23(4):407-16. PubMed ID: 19912591
[TBL] [Abstract][Full Text] [Related]
17. Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors.
Le Meur Y; Aulagnon F; Bertrand D; Heng AE; Lavaud S; Caillard S; Longuet H; Sberro-Soussan R; Doucet L; Grall A; Legendre C
Am J Transplant; 2016 Jul; 16(7):2181-6. PubMed ID: 26718625
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
[TBL] [Abstract][Full Text] [Related]
19. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction.
Scian MJ; Maluf DG; Archer KJ; Suh JL; Massey D; Fassnacht RC; Whitehill B; Sharma A; King A; Gehr T; Cotterell A; Posner MP; Mas V
Transplantation; 2011 Mar; 91(6):657-65. PubMed ID: 21242883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
